Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins
Open accessThe DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Abstract
Hemolysis occurs in many hematologic and nonhematologic diseases. Extracellular hemoglobin (Hb) has been found to trigger specific pathophysiologies that are associated with adverse clinical outcomes in patients with hemolysis, such as acute and chronic vascular disease, inflammation, thrombosis, and renal impairment. Among the molecular characteristics of extracellular Hb, translocation of the molecule into the extravascular space, oxidative and nitric oxide reactions, hemin release, and molecular signaling effects of hemin appear to be the most critical. Limited clinical experience with a plasma-derived haptoglobin (Hp) product in Japan and more recent preclinical animal studies suggest that the natural Hb and the hemin-scavenger proteins Hp and hemopexin have a strong potential to neutralize the adverse physiologic effects of Hb and hemin. This includes conditions that are as diverse as RBC transfusion, sickle cell disease, sepsis, and extracorporeal circulation. This perspective reviews the principal mechanisms of Hb and hemin toxicity in different disease states, updates how the natural scavengers efficiently control these toxic moieties, and explores critical issues in the development of human plasma–derived Hp and hemopexin as therapeutics for patients with excessive intravascular hemolysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The mechanisms underlying the pathogenic effects of extracellular hemoglobin were associated originally to NO scavenging, reducing NO bioavailability, and impairing microvascular homeostasis [192,196] (Fig 4).”
From The Iron age of host–microbe interactions (2015) · cites this paper as [196]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of the haemoglobin scavenger receptor
Kristiansen, M., Graversen, J. H., Jacobsen, C., Sonne, O., Hoffman, H.-J., Law, S. K. A., & Moestrup, S. K. (2001) · Nature · doi:10.1038/35051594 · Cited by 1,712
Rother, R. P., Bell, L., Hillmen, P., & Gladwin, M. T. (2005) · JAMA · doi:10.1001/jama.293.13.1653 · Cited by 1,557
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., Hogg, N., Cannon, R. O., Schechter, A. N., & Gladwin, M. T. (2002) · Nature Medicine · doi:10.1038/nm1202-799 · Cited by 1,330
Pulmonary Hypertension as a Risk Factor for Death in Patients with Sickle Cell Disease
Gladwin, M. T., Sachdev, V., Jison, M. L., Shizukuda, Y., Plehn, J. F., Minter, K., Brown, B., Coles, W. A., Nichols, J. S., Ernst, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035477 · Cited by 1,325
Cell-free hemoglobin limits nitric oxide bioavailability in sickle-cell disease
Reiter, C. D., Wang, X., Tanus-Santos, J. E., et al. (2002) · Nature Medicine · doi:10.1038/nm799 · Cited by 1,097
Pro-oxidant and cytotoxic effects of circulating heme
Jeney, V., Balla, J., Yachie, A., Varga, Z., Vercellotti, G. M., Eaton, J. W., & Balla, G. (2002) · Blood · doi:10.1182/blood.v100.3.879 · Cited by 633
Self-citationCharacterization of Heme as Activator of Toll-like Receptor 4
Figueiredo, R. T., Fernandez, P. L., Mourao-Sa, D. S., Porto, B. N., Dutra, F. F., Alves, L. S., Oliveira, M. F., Oliveira, P. L., Graça-Souza, A. V., & Bozza, M. T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610737200 · Cited by 576
Donadee, C., Raat, N. J. H., Kanias, T., Tejero, J., Lee, J. S., Kelley, E. E., Zhao, X., Liu, C., Reynolds, H., Azarov, I., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.008698 · Cited by 572
Identification of heme as the ligand for the orphan nuclear receptors REV-ERBα and REV-ERBβ
Raghuram, S., Stayrook, K. R., Huang, P., Rogers, P. M., Nosie, A. K., McClure, D. B., Burris, L. L., Khorasanizadeh, S., Burris, T. P., & Rastinejad, F. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1344 · Cited by 558
Ogawa, K. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2835 · Cited by 528
Cited by
Platelet-Rich Plasma: New Performance Understandings and Therapeutic Considerations in 2020
(2020) · doi:10.3390/ijms21207794 · Cited by 1,039
“As a consequence, the RBC cell membrane disintegrates and releases toxic hemoglobin (Hb), measured as plasma-free hemoglobin (PFH), hemin, and iron [75].”
BackgroundBelcher, J. D., Chen, C., Nguyen, J., Milbauer, L., Abdulla, F., Alayash, A. I., Smith, A., Nath, K. A., Hebbel, R. P., & Vercellotti, G. M. (2014) · Blood · doi:10.1182/blood-2013-04-495887 · Cited by 695
“Specifically, this study examined the hypothesis that heme, released from plasma Hb during hemolysis, is an extracellular cell-signaling molecule and a causal factor in the development of vascular inflammation and vaso-occlusion in SCD.”
BackgroundInfluentialSelf-citationIba, T., & Levy, J. H. (2018) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.13911 · Cited by 552
“These events can be helpful if they only occur within a compartmentalized space, like an immunothrombus; however, free heme can spill out of the thrombus and into the circulation [65].”
A Dual Role of Heme Oxygenase-1 in Cancer Cells
Chiang, S.-K., Chen, S.-E., & Chang, L.-C. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms20010039 · Cited by 465
“In plasma, free heme can be scavenged by hemopexin or degraded by HO-1 to generate biliverdin, CO, and ferrous iron [68].”
BackgroundExtracorporeal Membrane Oxygenation—Hemostatic Complications
Murphy, D. A., Hockings, L. E., Andrews, R. K., Aubron, C., Gardiner, E. E., Pellegrino, V. A., & Davis, A. K. (2015) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2014.12.001 · Cited by 455
“Intravascular hemolysis is characterized by an increase in plasma-free hemoglobin (PFHb) and is associated with significant complications including renal failure and multiorgan failure [119,120].”
Background
Metadata
- Authors
- Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D., & Vercellotti, G. M.
- Affiliations
- University Hospital Zurich (CH)
- Center for Biologics Evaluation and Research (US)
- University of Minnesota (US)
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2013-02-21
- Volume
- 121
- Issue
- 8
- Pages
- 1276-1284
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- PMC
- PMC3578950
- OpenAlex
- W2026254409
- Cited by
- 754
- References
- 100
- Citations by year
- 2026: 43 · 2025: 49 · 2024: 64 · 2023: 47 · 2022: 68 · 2021: 57 · 2020: 70 · 2019: 65 · 2018: 66 · 2017: 53 · 2016: 56 · 2015: 56 · 2014: 41 · 2013: 16
- FWCI
- 3.33
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Blood (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion, other-oa)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- National Science Foundation (310030)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (31003A, 138500, 120658, 310030)
- Kommission für Technologie und Innovation
- Universität Zürich
- National Institutes of Health (HL115467-01, 5p01hl055552-15, HL-55552, HL110900)
- U.S. Food and Drug Administration
- National Heart, Lung, and Blood Institute (P01-HL055552, R01HL114567, HL 110900, P01HL110900, P01 HL55552, R01 HL115467-01)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Hemoglobin structure and function
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Keywords
- hemolysis, extracellular hemoglobin, hemin, haptoglobin, hemopexin, hemoglobin toxicity, nitric oxide, oxidative stress, sickle cell disease, sepsis, red blood cell transfusion, extracorporeal circulation
- MeSH terms
- Animals, Haptoglobins, Hematologic Diseases, Hemin, Hemoglobins, Hemolysis, Hemopexin, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. https://app.cochat.ai/papers/10.1182/blood-2012-11-451229
- The paper
- Schaer, D. J., Buehler, P. W., Alayash, A. I., Belcher, J. D., & Vercellotti, G. M. (2013). Hemolysis and free hemoglobin revisited: exploring hemoglobin and hemin scavengers as a novel class of therapeutic proteins. Blood. https://doi.org/10.1182/blood-2012-11-451229
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.